Product Information
OFLOXACIN 0.3% EAR DROPS is a generic product labeled by NorthStar Rx LLC, priced at $0.9789 per ML under NDC 72603018602. Its NADAC has been published 131 times since Apr 3, 2024.
FDA first approved this application on Jul 14, 2022. Its Orange Book therapeutic-equivalence code is AT.
Strength
3 mg/mL
Manufacturer
NorthStar Rx LLCNDC
72603018602
Classification
Generic
Dosage Form
SOLUTION
Route
AURICULAR (OTIC)
Effective Date
9/23/2026
Active Ingredients
OFLOXACINApproval Type
Generic (ANDA)
FDA Application
ANDA216130FDA Approved
7/14/2022
TE Code
AT
On Market Since
12/1/2023
Pharmacological Classes
Price Statistics
The NADAC for OFLOXACIN 0.3% EAR DROPS has been published 131 times since Apr 3, 2024, and over the history we have for it it has declined 44.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9789 per ML |
|---|---|
| All-time high | $1.7654 (Apr 10, 2024) |
| All-time low | $0.9468 (May 20, 2026) |
| 52-week high | $1.2312 |
| 52-week low | $0.9468 |
| Median price | $1.1997 |
| Average price | $1.2315 |
| Largest weekly change | +61.9% (Aug 21, 2024) |
| Weeks tracked | 131 |
| Tracking since | Apr 3, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ofloxacin otic market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Quinolone Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OFLOXACIN 0.3% EAR DROPS?
The current National Average Drug Acquisition Cost (NADAC) for OFLOXACIN 0.3% EAR DROPS, manufactured by NorthStar Rx LLC, is $0.9789 per ML (NDC 72603018602), effective Sep 30, 2026.
How has the price of OFLOXACIN 0.3% EAR DROPS changed over time?
Over the history we have for it, the NADAC for OFLOXACIN 0.3% EAR DROPS has declined 44.5%. It has been tracked across 131 weekly CMS publications since Apr 3, 2024.
What are the highest and lowest recorded NADAC prices for OFLOXACIN 0.3% EAR DROPS?
Since Apr 3, 2024, the NADAC for OFLOXACIN 0.3% EAR DROPS has ranged from a low of $0.9468 (May 20, 2026) to a high of $1.7654 (Apr 10, 2024), with a median of $1.1997 per ML.
Are there cheaper alternatives to OFLOXACIN 0.3% EAR DROPS?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OFLOXACIN 0.3% EAR DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures OFLOXACIN 0.3% EAR DROPS?
OFLOXACIN 0.3% EAR DROPS (NDC 72603018602) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.